Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Research on breast cancer published by R.J. Bleicher et al
June 18th, 2009
"Methylene blue (MB) dye has been used for lymphatic mapping/sentinel lymphadenectomy (LM/SL) in staging of melanoma and breast cancer. It has been noted to cause skin necrosis, but its more mild adverse effects from intraparenchymal breast injections are not well characterized," scientists in the United States report. "patients undergoing LM/SL fro breast cancer and melanoma were reviewed, with attention devoted to skin manifestations. Patients undergoing mastectomies were excluded to rule out changes from flap devascularizations. All breast patients were injected intraparenchymally. Ninety-five patients underwent MB injection during a nationwide shortage of...
Source: Women's Health Weekly (2009-06-18)
|
